Trial
NCT04102124
A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Prostate Cancer
Intervention
SHR3680
Why stopped
The sponsor's R\&D strategy is adjusted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-24